Press Releases

May 1, 2014	Summary Toggle Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards PISCATAWAY, N.J. --(BUSINESS WIRE)-- Enzon Pharmaceuticals, Inc.	Enzon Adopts Stockholder Rights Plan in an Effort to Protect Net Operating Loss Carryforwards 11.8 KB
Apr 23, 2013	Summary Toggle Enzon Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends PISCATAWAY, NJ -- (Marketwired) -- 04/23/13 -- Enzon Pharmaceuticals, Inc.	Enzon Concludes Review of Possible Asset Sales, Sale of the Company; Announces $1.60 Special Dividend and Periodic Royalty Dividends 13 KB
Mar 18, 2013	Summary Toggle Enzon Reports Fourth Quarter and Full Year 2012 Results PISCATAWAY, NJ -- (Marketwire) -- 03/18/13 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced its financial results for the fourth quarter and full year 2012.	Enzon Reports Fourth Quarter and Full Year 2012 Results 25.5 KB
Dec 17, 2012	Summary Toggle Enzon to Review Asset Sales, Sale of the Company PISCATAWAY, NJ -- (Marketwire) -- 12/17/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that its Board of Directors has retained Lazard to act as financial advisor in a review of the possible sale or disposition of one or more corporate assets, or a sale of the Company.	Enzon to Review Asset Sales, Sale of the Company 11.3 KB
Nov 29, 2012	Summary Toggle Enzon Announces Special Dividend PISCATAWAY, NJ -- (Marketwire) -- 11/29/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that its Board of Directors has authorized a special dividend of $2.00 per common share, payable on December 21, 2012 to shareholders of record as of December 10, 2012 .	Enzon Announces Special Dividend 10.5 KB
Nov 8, 2012	Summary Toggle Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China PISCATAWAY, NJ -- (Marketwire) -- 11/08/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced two oral presentations at the 2nd Annual Symposium of Drug Delivery Systems-2012, which is being held November 8-10 in Nanjing , China .	Enzon Announces Two Oral Presentations at the Symposium of Drug Delivery Systems in Nanjing, China 14.2 KB
Oct 31, 2012	Summary Toggle Enzon Reports Third Quarter 2012 Results PISCATAWAY, NJ -- (Marketwire) -- 10/31/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced its financial results for the third quarter of 2012.	Enzon Reports Third Quarter 2012 Results 21.7 KB
Sep 11, 2012	Summary Toggle Enzon to Present at 2012 World Congress and Expo on Biowaivers and Biosimilars PISCATAWAY, NJ -- (Marketwire) -- 09/11/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced that it will present at the 2012 World Congress and Expo on Biowaivers and Biosimilars , which is being held September 10-12 in San Antonio, TX.	Enzon to Present at 2012 World Congress and Expo on Biowaivers and Biosimilars 13.3 KB
Aug 1, 2012	Summary Toggle Enzon Reports Second Quarter 2012 Results PISCATAWAY, NJ -- (Marketwire) -- 08/01/12 -- Enzon Pharmaceuticals, Inc. (NASDAQ: ENZN) today announced its financial results for the second quarter of 2012.	Enzon Reports Second Quarter 2012 Results 22.3 KB
Jul 16, 2012	Summary Toggle Enzon Presents Pre-Clinical Data on Controlled Release of PEGylated Interferon-Beta-1b and PEGylated anti-TNF-a Antibody Fragment at the Controlled Release Society Annual Meeting PISCATAWAY, NJ -- (Marketwire) -- 07/16/12 -- Enzon Pharmaceuticals, Inc.	Enzon Presents Pre-Clinical Data on Controlled Release of PEGylated Interferon-Beta-1b and PEGylated anti-TNF-a Antibody Fragment at the Controlled Release Society Annual Meeting 65.9 KB